Cathay Biotech Inc (688065) — Cash Flow Quality Index
Cathay Biotech Inc (688065) has a Cash Flow Quality Index of -0.47x as of September 2025. Operating cash flow of CN¥-66.22 Million is below net income of CN¥142.01 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 688065 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cathay Biotech Inc Cash Flow Quality Index (2016–2025)
Historical Cash Flow Quality Index for Cathay Biotech Inc across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 688065 cash generation efficiency.
Annual Cash Flow Quality Index for Cathay Biotech Inc (2016–2025)
Year-by-year earnings quality comparison for Cathay Biotech Inc.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.71x | CN¥404.12 Million | CN¥565.72 Million | ▼ -58.7% |
| 2024 | 1.73x | CN¥820.93 Million | CN¥474.59 Million | ▲ +11.3% |
| 2023 | 1.55x | CN¥569.45 Million | CN¥366.52 Million | ▲ +18.4% |
| 2022 | 1.31x | CN¥803.67 Million | CN¥612.65 Million | ▲ +42.8% |
| 2021 | 0.92x | CN¥594.18 Million | CN¥646.68 Million | ▼ -18.4% |
| 2020 | 1.13x | CN¥514.96 Million | CN¥457.34 Million | ▲ +49.9% |
| 2019 | 0.75x | CN¥359.62 Million | CN¥478.88 Million | ▲ +3504.1% |
| 2018 | -0.02x | CN¥-10.29 Million | CN¥466.29 Million | ▼ -113.7% |
| 2017 | 0.16x | CN¥53.45 Million | CN¥332.73 Million | ▲ +118.2% |
| 2016 | -0.88x | CN¥-128.67 Million | CN¥145.47 Million | — |